These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


127 related items for PubMed ID: 943955

  • 21. Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome.
    Mann J, Thomas KM.
    Br J Psychiatry; 1979 Apr; 134():366-71. PubMed ID: 36192
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Reduction of blood platelet monoamine oxidase activity in schizophrenic patients on phenothiazines.
    Takahashi S, Yamane H, Tani N.
    Folia Psychiatr Neurol Jpn; 1975 Apr; 29(3):207-14. PubMed ID: 2524
    [Abstract] [Full Text] [Related]

  • 24. Platelet MAO activity and schizophrenic prognosis.
    Gruen R, Baron M, Levitt M, Asnis L.
    Am J Psychiatry; 1982 Feb; 139(2):240-1. PubMed ID: 7055302
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Brain and skeletal muscle monoamine oxidase activity in schizophrenia.
    Meltzer HY, Jackman H, Arora RC.
    Schizophr Bull; 1980 Feb; 6(2):208-12. PubMed ID: 6103574
    [Abstract] [Full Text] [Related]

  • 29. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B, Kosower N, Zipser Y, Shreiber-Schul N, Apter A, Tyano S, Weizman A.
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [Abstract] [Full Text] [Related]

  • 30. Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity.
    Sullivan JL, Coffey CE, Basuk B, Cavenar JO, Maltbie AA, Zung WW.
    Biol Psychiatry; 1980 Feb; 15(1):113-20. PubMed ID: 7357050
    [Abstract] [Full Text] [Related]

  • 31. Platelet monoamine oxidase in families of chronic schizophrenics.
    Berrettini WH, Benfield TC, Schmidt AO, Ladman RK, Vogel WH.
    Schizophr Bull; 1980 Feb; 6(2):235-7. PubMed ID: 7375856
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. MAO activity, csf amine metabolites, and drug-free improvement in schizophrenia.
    Van Kammen DP, Marder SR, Murphy DL, Bunney WE.
    Am J Psychiatry; 1978 May; 135(5):567-9. PubMed ID: 645949
    [Abstract] [Full Text] [Related]

  • 36. Platelet monamine oxidase in schizophrenia. An investigation in drug-free chronic hospitalized patients.
    Owen F, Bourne R, Crow TJ, Johnstone EC, Bailey AR, Hershon HI.
    Arch Gen Psychiatry; 1976 Nov; 33(11):1370-3. PubMed ID: 791182
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients.
    Meltzer HY, Stahl SM.
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):419-31. PubMed ID: 4594367
    [No Abstract] [Full Text] [Related]

  • 39. Platelet monoamine oxidase activity in subgroups of schizophrenic disorders.
    Schildkraut JJ, Orsulak PJ, Schatzberg AF, Herzog JM.
    Schizophr Bull; 1980 Feb; 6(2):220-5. PubMed ID: 7375853
    [Abstract] [Full Text] [Related]

  • 40. Platelet monamine oxidase in chronic schizophrenia. Some enzyme characteristics relevant to reduced activity.
    Murphy DL, Donnelly CH, Miller L, Wyatt RJ.
    Arch Gen Psychiatry; 1976 Nov; 33(11):1377-81. PubMed ID: 985048
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.